Operating Expenses Zmiana Data
Adma Biologics USD 85.84M 27.26M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
Dynavax Technologies USD 64.09M 311K 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Immunic USD 23.57M 1.45M 2023-09
Insmed USD 261.96M 35.22M 2023-12
Knight Therapeutics CAD 79.21M 9.9M 2023-09
Omeros USD 48.15M 7.25M 2023-09
Pacira USD 148.08M 1.87M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Regulus Therapeutics USD 8.12M 810K 2023-09
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
United Therapeutics USD 354.6M 72.2M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09
Xoma USD 6.62M 998K 2023-09



Omeros Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.